MDA vs RTX

MDA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational efficiency. The stock is trading at a significant premium, with a current price of $29.10 far exceeding both the Graham Number ($10.37) and the growth-based Intrinsic Value ($5.64). While recent Q/Q revenue growth of 44% shows short-term momentum, the stagnant YoY revenue growth (0.20%) and thin profit margins (2.24%) fail to justify the high P/E ratio of 46.94. The combination of a bearish technical trend and poor deterministic scores suggests a high risk of price correction.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.